Microline Surgical Inc
$45.6K 171 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Fortis Surgical, LLC
Fortis Surgical, LLC reported $45,563.47 across General Payments, Research, and Ownership to 464 physicians and teaching hospitals across 464 transactions.
- $45.6K Below-median payer
- All-tracks total
- 464 Above-median volume
- Transactions
- 464 Above-median reach
- Recipients
- +$12.5K
- General Payments vs PY2023
Fortis Surgical, LLC reported $45,563.47 across all CMS Open Payments tracks (General + Research + Ownership) to 464 physicians and teaching hospitals in Program Year 2024 - ranking #1375 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $45,563.47, averaging $98.20 per recipient.
Fortis Surgical, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
15/100
Total payments
F
10/100
Transaction volume
F
13/100
Physician reach
F
13/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer fortis-surgical-llc Fortis Surgical, LLC
$45.6K · #1375/1,925 · 0.0% industry · PY2024
- TOT $45.6K
- RANK #1375
- SHARE 0.0%
- TXN 464
- RCP 464
- CAT 2
- GEN $45.6K
- ΔGEN +$12.5K
- TOP1 4.5%
- PY 2024
Volume peers
Nearest volume peer: Microline Surgical Inc ($45.6K)
Fortis Surgical, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Fortis Surgical, LLC's CMS-reported General Payments increased by $12.5K (+37.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: FORTIS SURGICAL, LLCPY2023: FORTIS SURGICAL, LLCPY2024: Fortis Surgical, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $33,068.16
- PY2024
- $45,563.47
What the Data Shows for Fortis Surgical, LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Fortis Surgical, LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
"Travel and Lodging" leads the 2-category general-payment breakdown below at $29.4K (64.5% of General Payments, 83 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Fortis Surgical, LLC made 2 types of general payments. "Travel and Lodging" is the largest category at $29.4K, 64.5% of General Payments.
How Fortis Surgical, LLC divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Travel and Lodging | $29.4K | 83 | 64.5% |
| Food and Beverage | $16.2K | 381 | 35.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $8,056.84 (17.7%) of $45,563.47 in this company's General Payments records across 231 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Fortis Surgical, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Victoria Matt
$2,038.29 across 5 reported transactions
- 2
Brian Huff
$2,022.80 across 10 reported transactions
- 3
Jessica Bruno
$1,409.27 across 9 reported transactions
- 4
Bryanna Vesely
$1,371.26 across 10 reported transactions
- 5
Jennifer Vanderbeck
$1,215.22 across 9 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Fortis Surgical, LLC ranks #1375 of 1,925 by total payments (bottom 29% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,608 of 1,838 by HHI (bottom 13% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Alexion Pharmaceuticals, Inc. : $12.5M total payments, HHI 164
- Titan Surgical Group, Llc : $40.3K total payments, HHI 164
- Polaris Technology Solutions LLC : $39.0K total payments, HHI 164
- Ambu Inc. : $233.8K total payments, HHI 164
- TG Therapeutics, Inc. : $4.7M total payments, HHI 163
- Johnson & Johnson Surgical Vision, Inc. : $1.6M total payments, HHI 163
- Fortis Surgical, LLC (this company) : $45.6K total payments, HHI 163
- Deciphera Pharmaceuticals Inc. : $602.7K total payments, HHI 162
- Radius Health, Inc. : $792.8K total payments, HHI 162
- Kuros Biosciences USA, Inc : $711.3K total payments, HHI 162
- Merz Pharmaceuticals, LLC : $919.5K total payments, HHI 162
- Vanda Pharmaceuticals Inc. : $4.6M total payments, HHI 160
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Fortis Surgical, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Fortis Surgical, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Fortis Surgical, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Mercator MedSystems, Inc.
$45.4K 12 recipients
Compare payment profiles
Hollister Incorporated
$45.3K 370 recipients
Compare payment profiles
Hartmann USA, Inc.
$45.9K 479 recipients
Compare payment profiles
Curium US LLC
$45.9K 103 recipients
Compare payment profiles
AnX Robotica Corp
$45.9K 69 recipients
Compare payment profiles
Put this to use
Fortis Surgical, LLC ranks #1375 of 1,925 by all-tracks total payments, led by "Travel and Lodging".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Travel and Lodging" spend across every manufacturer, not just Fortis Surgical, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.